SIGMACEF-TAZO INJ.

SIGMACEF-TAZO 562.5 mg

Composition

Each Vial contains :

• Ceftriaxone        I.P.                  500 mg
• Tazobactam Sodium               62.50 mg

Indications

• Lower Respiratory Tract Infection (LRTI)
• Skin Injections
• Bacterial Septicaemia
• Bone & Joint Infection
• Meningitis
• Acute Bacterial Otitis Media
• Intra abdominal infection
• Pelvic Inflammatory disease

Dose

• Dogs & calf:- 15-25 mg b.wt. daily IM/IV for 3 to 5 days

Packing

562.50mg Vial with 5 ml DW.